SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules.
Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.
Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their R&D goals
Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.
Home » About Us » Corporate Social Responsibility » CSR Initiative: Syngene Early Career Research Grants 2026-27
Syngene International Limited is India’s prominent integrated Contract Research, Development and Manufacturing Organization (CRDMO), providing a comprehensive set of services that span the entire drug discovery and development spectrum. From understanding the fundamentals of disease biology to advancing drug candidates through clinical trials, Syngene’s integrated approach ensures safety, efficacy, and scalability. Syngene actively incorporates multiple modalities including small molecules and biologics and specialized platforms like heterobifunctional molecules, mRNA, Antibody-Drug Conjugates (ADCs), peptides, oligonucleotides and cell therapy into its service offerings. Syngene also continuously invests in advanced technologies including the development of proprietary platforms and novel targets for more efficient drug discovery. Syngene’s expertise spans a range of therapeutic areas. Our small and large molecule development and manufacturing services offer scale and quality for clinical and commercial supplies of drug substance and drug product.
As part of our Corporate Social Responsibility (CSR) program, Syngene International Limited (“Syngene” or “we” or “our”) invites applications from Junior Faculty (Assistant Professors or equivalent) engaged in life sciences Research at Indian research institutes and universities for Syngene Early Career Research Grant (SECRG) 2026-2027. These grants are intended to help promising junior faculty establish research independence and work on high risk-high reward projects to foster innovative solutions for healthcare.
This initiative seeks to:
Why should you apply?
This call is open to Junior Researchers working at the intersection of biology, chemistry, technology, and computation to address key challenges in modern drug discovery. We invite applications for research in life sciences that advance innovation in drug discovery and development, with a focus on (but not limited to):
The application process consists of two stages:
Stage 1: Online Application
Applicants must complete the application process by clicking this link below by November 30, 2026.
Syngene SECRG Application Form
This includes:
Up to 10 candidates will be shortlisted based on the Stage 1 submissions.
Completion of all Stage 1 steps is mandatory to be considered for the next phase.
Stage 2: Interview Round
Shortlisted candidates will be invited for a 30-minute virtual interview that will include a 20-minute presentation from each candidate followed by questions. Based on the jury’s scoring, 3 candidates will be selected at Syngene’s sole discretion to receive the Syngene Early Career Research Grant. Candidates will be notified of the selection results by February 1, 2027. In addition, one of the grant recipients will also be selected to receive the 2027 Syngene Young Investigator Award at an Award ceremony hosted at Syngene’s Bengaluru premises.
To begin your application, please visit the Syngene SECRG Application Form to complete Stage 1 of the application process.
For further information or clarification, kindly write to earlycareer.grants@syngeneintl.com
At Syngene, we are committed to protecting the privacy and security of your personal information. By submitting your application for research funding, you acknowledge and consent to the following:
Data Collection:
We will collect the following information from you:
Data Usage:
The information collected will be used for administering, reviewing, evaluating your application for the program and communicating with you regarding the outcome of the application process.
Data Retention:
Personal data collected during this process will be retained only for as long as necessary to administer and complete the application review process and comply with applicable legal and record-keeping requirements, following which it will be securely deleted or anonymized.
Data Security:
Syngene maintains appropriate administrative, physical, and technical safeguards to protect your personal data from unauthorized access, disclosure, alteration, or destruction.
By submitting your application, you acknowledge that you have read and understood this Privacy Notice and consent to the collection, use, retention, and otherwise processing of your data as outlined above by Syngene.
If you have any questions or concerns about our privacy practices, please contact us at DPO@syngeneintl.com.